Scinai Immunotherapeutics (SCNI) Non Operating Income (2014 - 2026)
Scinai Immunotherapeutics (SCNI) reported Non Operating Income of -$112000.0 for Q1 2026, down 1118.18% on a YoY basis from $11000.0 in Q1 2025, and down 1118.18% sequentially from $11000.0 in Q1 2025.
Scinai Immunotherapeutics (SCNI) Non Operating Income (2014 - 2026) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 9 years of Non Operating Income data on file, last reported at -$112000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 1118.18% year-over-year to -$112000.0; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (down 44.29% YoY), and the FY2025 full-year result was -$1.2 million, up 8.23% from the prior year.
- Non Operating Income eased to -$112000.0 in Q1 2026, from $11000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $12.6 million in Q4 2022 to a low of -$6.9 million in Q3 2022.
- A 4-year average of $799200.0 and a median of -$50500.0 in 2025 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income soared 516.79% in 2023 and slumped 1118.18% in 2026, its largest moves.
- Tracing SCNI's Non Operating Income over 4 years: stood at $12.6 million in 2022, then slumped by 45.19% to $6.9 million in 2023, then slumped by 99.84% to $11000.0 in 2025, then tumbled by 1118.18% to -$112000.0 in 2026.
- Business Quant data shows SCNI's Non Operating Income at -$112000.0 in Q1 2026, $11000.0 in Q1 2025, and $6.9 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -8.59 Mn |
| 10 | Scinai Immunotherapeutics | 3.54 Bn | 424.15 Mn | -1.12 Mn | -112,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -112,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Dec 31, 2023 | 6.92 Mn |
| Sep 30, 2023 | -5.21 Mn |
| Jun 30, 2023 | 1.17 Mn |
| Mar 31, 2023 | -329,000.00 |
| Dec 31, 2022 | 12.62 Mn |
| Sep 30, 2022 | -6.94 Mn |
| Jun 30, 2022 | -280,000.00 |
| Mar 31, 2022 | 140,000.00 |
| Mar 31, 2021 | -297,000.00 |
| Sep 30, 2019 | -260,000.00 |
| Jun 30, 2019 | -4.98 Mn |
| Mar 31, 2019 | -618,000.00 |
| Sep 30, 2018 | 992,000.00 |
| Dec 31, 2015 | 599,000.00 |
| Sep 30, 2015 | -2.35 Mn |
| Dec 31, 2014 | -206,000.00 |
| Sep 30, 2014 | -160,000.00 |